| dc.contributor |
Wichita State University. Department of Communication Sciences and Disorders |
en_US |
| dc.contributor.author |
Self, Trisha L. |
en_US |
| dc.contributor.author |
Hale, LaDonna S. |
en_US |
| dc.contributor.author |
Crumrine, Daiquirie |
en_US |
| dc.date.accessioned |
2012-02-29T18:34:48Z |
|
| dc.date.available |
2012-02-29T18:34:48Z |
|
| dc.date.issued |
2010-07 |
en_US |
| dc.identifier |
20543026 |
en_US |
| dc.identifier |
0323431 |
en_US |
| dc.identifier |
0161-1461_2009_08-0106 |
en_US |
| dc.identifier.citation |
Language, speech, and hearing services in schools. 2010 Jul; 41(3): 367-75. |
en_US |
| dc.identifier.issn |
1558-9129 |
en_US |
| dc.identifier.issn |
0161-1461 |
en_US |
| dc.identifier.uri |
http://dx.doi.org/10.1044/0161-1461(2009/08-0106) |
en_US |
| dc.identifier.uri |
http://hdl.handle.net/10057/4704 |
|
| dc.description |
Click on the DOI link below to access the article (may not be free). |
en_US |
| dc.description.abstract |
The purpose of this tutorial is to provide speech-language pathologists (SLPs) with general information regarding the most commonly prescribed medications for children with autism spectrum disorder (ASD; e.g., central nervous system stimulants, noradrenergic reuptake inhibitors, alpha-2 adrenergic agonists, antipsychotics, anticonvulsants, selective serotonin reuptake inhibitors, benzodiazepines) in regard to their mechanism of action, behaviors treated, and potential side effects. |
en_US |
| dc.format.extent |
367-75 |
en_US |
| dc.language.iso |
eng |
en_US |
| dc.publisher |
American Speech - Language - Hearing Association |
en_US |
| dc.relation.ispartofseries |
Language, Speech, and Hearing Services In Schools |
en_US |
| dc.relation.ispartofseries |
Lang Speech Hear Serv Sch |
en_US |
| dc.source |
NLM |
en_US |
| dc.subject.mesh |
Child |
en_US |
| dc.subject.mesh |
Child Development Disorders, Pervasive/drug therapy |
en_US |
| dc.subject.mesh |
Health Personnel/education |
en_US |
| dc.subject.mesh |
Humans |
en_US |
| dc.subject.mesh |
Patient Care Team |
en_US |
| dc.subject.mesh |
Psychotropic Drugs/adverse effects |
en_US |
| dc.subject.mesh |
Psychotropic Drugs/therapeutic use |
en_US |
| dc.subject.mesh |
Speech-Language Pathology/education |
en_US |
| dc.title |
Pharmacotherapy and children with autism spectrum disorder: a tutorial for speech-language pathologists |
en_US |
| dc.type |
Article |
en_US |
| dc.coverage.spacial |
United States |
en_US |
| dc.description.version |
peer reviewed |
en_US |
| dc.rights.holder |
Copyright © American Speech-Language-Hearing Association |
en_US |